Patent details

Basic Information

Publication number:

EP3031810

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151904364

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MAYTANSINOID-CELL-BINDING AGENT CONJUGATES

French Title of Invention:

CONJUGUÉS DE MAYTANSINOÏDE-AGENT DE LIAISON DE CELLULE

German Title of Invention:

MAYTANSINOID-ZELLBINDUNGSMITTEL-KONJUGATE

SPC Number:

Dates

Filing date:

20/05/2004

Grant date:

06/03/2019

EP Publication Date:

15/06/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/03/2019

EP B1 Publication Date:

06/03/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/05/2019

Expiration date:

20/05/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/02/2019

 

 

Name:

ImmunoGen, Inc.

Address:

830 Winter Street, Waltham, MA 02451, United States (US)

Inventor

1

Name:

Widdison, Wayne C.

Address:

United States (US)

2

Name:

Chari, Ravi V.J

Address:

United States (US)

Priority

Priority Number:

471739 P

Priority Date:

20/05/2003

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/5365; A61P 35/00; C07D 498/16; A61K 47/68;

Publication

European Patent Bulletin

1

Issue number:

201910

Publication date:

06/03/2019

Description:

Grant (B1)

2

Issue number:

201915

Publication date:

10/04/2019

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages